Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi
Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi
Full Journal - Journal of Cell and Molecular Biology - Haliç Üniversitesi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Journal</strong> <strong>of</strong> <strong>Cell</strong> <strong>and</strong> <strong>Molecular</strong> <strong>Biology</strong> 1: 81-85, 2002.<br />
Golden Horn University, Printed in Turkey.<br />
Effect <strong>of</strong> epirubicin <strong>and</strong> tamoxifen on labelling index in FM3A cells<br />
Mehmet Topçul 1 *, Gül Özcan Ar›can 1 , Nevin Erensoy 2 , Atilla Özalpan 3<br />
1 University <strong>of</strong> ‹stanbul, Faculty <strong>of</strong> Science, Department <strong>of</strong> <strong>Biology</strong>, 34459, Vezneciler, ‹stanbul, Turkey;<br />
2 University <strong>of</strong> ‹stanbul, Faculty <strong>of</strong> Cerrahpafla Medicine, Department <strong>of</strong> Medical <strong>Biology</strong>, ‹stanbul, Turkey;<br />
3 University <strong>of</strong> Golden Horn, Faculty <strong>of</strong> Arts <strong>and</strong> Sciences, Department <strong>of</strong> <strong>Molecular</strong> <strong>Biology</strong> <strong>and</strong><br />
Genetics, 34280, ‹stanbul, Turkey (* author for correspondence)<br />
Received 15 April 2002; Accepted 21 June 2002<br />
Abstract<br />
C3H mouse mammary carsinoma-derived FM3A cell line grown in RPMI 1640+10%FBS medium as suspension<br />
culture have been used in tissue culture studies in recent years. Changes in labelling index were examined in the<br />
present study, applying in vitro doses <strong>of</strong> epirubicin, tamoxifen <strong>and</strong> epirubicin+tamoxifen to FM3A cells. The<br />
findings reveal that treatments <strong>of</strong> epirubicin <strong>and</strong> tamoxifen lower the percentage <strong>of</strong> the cells at S phase, while<br />
combined treatment <strong>of</strong> epirubicin <strong>and</strong> tamoxifen gives more successful results, being statistically significant<br />
(p